Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR‑T cell therapy: A breakthrough in traditional cancer treatment strategies (Review)
Dahua Sun, Xiang Shi, Sanyan Li, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 17

Showing 17 citing articles:

STING activation and overcoming the challenges associated with STING agonists using ADC (antibody-drug conjugate) and other delivery systems
Hitesh Vasiyani, Bhumika Wadhwa
Cellular Signalling (2025), pp. 111647-111647
Closed Access | Times Cited: 1
Cellular immunotherapies and immune cell depleting therapies in inflammatory bowel diseases: the next magic bullet?
Markus F. Neurath, Bruce E. Sands, Florian Rieder
Gut (2024) Vol. 74, Iss. 1, pp. 9-14
Closed Access | Times Cited: 5
Synthetic Gene Circuits as a Promising Approach in Cancer Immunotherapy
Bhanuprakash Ananthakumar, Nagashri Nanjundeshwara, Archana Lakshmaiah, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 391-418
Closed Access | Times Cited: 5
The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap
Anneliene Hechtelt Jonker, Elena-Alexandra Tãtaru, Holm Graeßner, et al.
Nature Reviews Drug Discovery (2024) Vol. 24, Iss. 1, pp. 40-56
Closed Access | Times Cited: 5
HEBE: A novel chimeric chronokine for ameliorating memory deficits in Alzheimer’s disease
Jon Esandi, Pedro Renault, Maria Dolores Capilla-López, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117815-117815
Closed Access
CAR T-cell Therapy Landscape in Pediatric, Adolescent and Young Adult Oncology - A Comprehensive Analysis of Clinical Trials
David A Martínez-Gamboa, Rhea Hans, Eider Moreno-Cortes, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 209, pp. 104648-104648
Closed Access
CAR-T cell therapy in the treatment of relapsed or refractory primary central nervous system lymphoma: recent advances and challenges
Shankuo Xiong, S. Zhang, Ningning Yue, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-13
Closed Access
The potential applications of peptide-loading complex in cancer treatment
Zhidu Song, Ying Tao, Jiaxin You
Frontiers in Immunology (2025) Vol. 16
Open Access
The Application and Molecular Mechanisms of Mitochondria-Targeted Antioxidants in Chemotherapy-Induced Cardiac Injury
Chih-Jen Liu, Lu‐Kai Wang, Fu‐Ming Tsai
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 176-176
Open Access
Targeting the Immune Microenvironment in Chronic Lymphocytic Leukemia: An Evolving Therapeutic Strategy
Clement Chung, Duc Hoang Doan
European Journal Of Haematology (2025)
Closed Access
Extracellular vesicles as natural nanocarriers: From in vitro engineering to in situ generation in cancer therapy
Teng Zhang, Zimai Liu, Yuanyuan Wei, et al.
Chemical Engineering Journal (2025), pp. 161653-161653
Closed Access
Comprehensive strategies for constructing efficient CRISPR/Cas based cancer therapy: Target gene selection, sgRNA optimization, delivery methods and evaluation
Sathishbabu Paranthaman, Chinnappa A. Uthaiah, Shadab Md, et al.
Advances in Colloid and Interface Science (2025), pp. 103497-103497
Closed Access
DEVELOPMENT OF A CAR-T CELL PRODUCT IN A LOCAL LABORATORY SETTING: A STEP TOWARD ACCESSIBLE THERAPY IN KAZAKHSTAN
D. MENLAYAKOVA, Alexandr V. Shustov, Shynar Tanabayeva, et al.
Vestnik (2025), Iss. 1(72), pp. 28-42
Closed Access
Can antibodies be “vegan”? A guide through the maze of today’s antibody generation methods
Stefan Dübel
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Specific antitumor activity of anti-CA125 CAR-T lymphocytes against CA125-positive and CA125-negative cells
Т М Кулинич, Y.Y. Kiseleva, A. M. Shishkin, et al.
Sechenov Medical Journal (2024) Vol. 15, Iss. 2, pp. 36-47
Open Access
A Comprehensive ddPCR Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical Applications
Gertrud Wiedemann, Ulrike Bacher, Raphael Joncourt, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8556-8556
Open Access
Immunological aspects of HTLV-1 persistence; for the prevention and treatment of Adult T-cell leukaemia-lymphoma (ATL)
Devon A Weterings, Aileen Rowan, Lucy Cook
Leukemia Research (2024) Vol. 148, pp. 107635-107635
Open Access
Page 1

Scroll to top